5-Methylmethiopropamine

5-Methylmethiopropamine

5-Methylmethiopropamine

Stimulant designer drugs

5-Methylmethiopropamine (5-MMPA, mephedrene) is a stimulant drug which is a ring-substituted derivative of methiopropamine. It is not a substituted cathinone derivative like mephedrone, as it lacks a ketone group at the β position of the aliphatic side chain, but instead more closely resembles substituted amphetamines. It has been sold as a designer drug, first being identified in Germany in June 2020.[1][2][3]

Quick Facts Legal status, Identifiers ...

See also

References

  1. [1]
    EU Early Warning System Situation Report. Situation report 2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (Report). 10 August 2020.
  2. [2]
    "Info" (PDF). www.aekwien.at. Retrieved 2021-05-13.
  3. [3]
    New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. European Monitoring Center for Drugs and Drug Addiction, December 2020
Share this article:

This article uses material from the Wikipedia article 5-Methylmethiopropamine, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.